Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Enanta Pharmaceuticals (ENTA) Prepaid Assets (2016 - 2025)

Enanta Pharmaceuticals filings provide 14 years of Prepaid Assets readings, the most recent being $4.3 million for Q4 2025.

  • On a quarterly basis, Prepaid Assets fell 59.36% to $4.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $4.3 million, a 59.36% decrease, with the full-year FY2025 number at $8.6 million, down 30.8% from a year prior.
  • Prepaid Assets hit $4.3 million in Q4 2025 for Enanta Pharmaceuticals, down from $8.6 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $32.1 million in Q1 2021 to a low of $4.3 million in Q4 2025.
  • Median Prepaid Assets over the past 5 years was $12.8 million (2023), compared with a mean of $13.3 million.
  • Biggest five-year swings in Prepaid Assets: surged 62.04% in 2021 and later plummeted 59.36% in 2025.
  • Enanta Pharmaceuticals' Prepaid Assets stood at $11.5 million in 2021, then surged by 55.97% to $17.9 million in 2022, then fell by 26.2% to $13.2 million in 2023, then fell by 19.34% to $10.7 million in 2024, then plummeted by 59.36% to $4.3 million in 2025.
  • The last three reported values for Prepaid Assets were $4.3 million (Q4 2025), $8.6 million (Q3 2025), and $10.2 million (Q2 2025) per Business Quant data.